Benchling for Hybridoma Technology
Hybridoma technology is a well-established method for generating monoclonal antibodies (mAB), but various scientific and organizational challenges persist. Laborious and resource-intensive processes, low titers, and complex assays mean that scientists have to streamline every step, simplify handoffs, and track large amounts of complex data. Robust data management is key to effectively leveraging this antibody technology.
This data sheet covers:
The complexities faced with hybridoma technology
How Benchling helps teams manage the entire process of generating monoclonal antibodies
Differentiated features that have helped organizations effectively manage this antibody technology